Estimating health utilities in patients with asthma and COPD: evidence on the performance of EQ-5D and SF-6D
Rent the article at a discountRent now
* Final gross prices may vary according to local VAT.Get Access
The objective of this study was to understand systematic differences in utility values derived from the EQ-5D and the SF-6D in two respiratory populations with heterogeneous disease severity.
This study involved secondary analysis of data from two cross-sectional surveys of patients with asthma (N = 228; Hungary) and COPD (N = 176; Sweden). Disease severity was defined according to GINA and GOLD guidelines for asthma and COPD, respectively. EQ-5D and SF-6D scores and their distributional characteristics were compared across the two samples by disease severity level.
Within each patient population, mean EQ-5D and SF-6D scores were similar for the overall group and for those with moderate disease. Mean scores varied for patients with mild and severe disease. EQ-5D versus SF-6D scores in the asthma group by severity levels were 0.89 versus 0.80, 0.70 versus 0.73, 0.63 versus 0.64, and 0.51 versus 0.63, respectively. EQ-5D versus SF-6D scores in the COPD group by severity levels were 0.85 versus 0.80, 0.73 versus 0.73, 0.74 versus 0.73, and 0.53 versus 0.62, respectively.
Results suggest the EQ-5D and SF-6D do not yield consistent utility values in patients with asthma and COPD due to differences in underlying valuation techniques and the EQ-5D’s limited response options relative to mild disease.
- Hawthorne, G, Richardson, J, Day, NA (2001) A comparison of the assessment of quality of life (AQoL) with four other generic utility instruments. Annals of Medicine 33: pp. 358-370 CrossRef
- Kopec, JA, Willison, KD (2003) A comparative review of four preference-weighted measures of health-related quality of life. Journal of Clinical Epidemiology 56: pp. 317-325 CrossRef
- EuroQoL: a new facility for the measurement of health-related quality of life. Health Policy (Amsterdam) 16: pp. 199-208
- Brazier, J, Roberts, J, Deverill, M (2002) The estimation of a preference-based measure of health from the SF-36. Journal of Health Economics 21: pp. 271-292 CrossRef
- WHO Strategy for prevention and control of Chronic Respiratory Diseases. www.who.int.
- Szende, A, Svensson, K, Stahl, E, Meszaros, A, Berta, GY (2004) Psychometric and utility-based measures of health status of asthmatic patients with different disease control level. PharmacoEconomics 22: pp. 537-547 CrossRef
- Global initiative for asthma (GINA) guidelines. (1998). Global Strategy for Asthma Management and Prevention NHLBI/WHO Workshop Report.
- Ståhl, E, Lindberg, A, Rönmark, E, Svensson, K, Jansson, S-A, Andersson, F, Lundbäck, B (2001) The level of health-related quality of life in patients with COPD and its dependence on age, gender, and disease severity. The European Respiratory Journal 18: pp. 184s
- Pauwels, RA, Buist, AS, Calverley, PM, Jenkins, CR, Hurd, SS (2001) Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary. American Journal of Respiratory and Critical Care Medicine 163: pp. 1047-1048
- Szende, A., Oppe, M., & Devlin, N. (Eds.), (2007). The European VAS value set. In EQ–5D value sets. Inventory, comparative review and user guide (pp. 83–85). Dordrecht: Springer.
- Dolan, P (1997) Modeling valuations for EuroQol health states. Medical Care 35: pp. 1095-1108 CrossRef
- Green, C, Brazier, J, Deverill, M (2000) A Review of health state valuation techniques. PharmacoEconomics 17: pp. 151 CrossRef
- Dolan, P, Sutton, M (1997) Mapping VAS scores onto TTO and SG utilities. Social Science and Medicine 44: pp. 1289-1297
- Johnson, JA, Pickard, AS (2000) Comparison of the EQ-5D and SF-12 health surveys in a general population survey in Alberta, Canada. Medical Care 38: pp. 115-121 CrossRef
- Badia, X, Schiaffino, A, Alonso, J, Herdman, M (1998) Using the EuroQoI 5-D in the Catalan general population: feasibility and construct validity. Quality of Life Research 7: pp. 311-322 CrossRef
- Bharmal, M, Thomas, J (2006) Comparing the EQ-5D and the SF-6D descriptive systems to assess their ceiling effects in the US general population. Value in Health 9: pp. 262-271 CrossRef
- Konig, HH, Ulshofer, A, Gregor, M, Tirpitz, C, Reinshagen, M, Adler, G, Leidl, R (2002) Validation of the EuroQol questionnaire in patients with inflammatory bowel disease. European Journal of Gastroenterology and Hepatology 14: pp. 1205-1215 CrossRef
- Wu, AW, Jacobson, KL, Frick, KD, Clark, R, Revicki, DA, Freedberg, KA, Scott-Lennox, J, Feinberg, J (2002) Validity and responsiveness of the EuroQol as a measure of health-related quality of life in people enrolled in an AIDS clinical trial. Quality of Life Research 11: pp. 273-282 CrossRef
- Conner-Spady, B, Suarez-Almazor, ME (2003) Variation in the estimation of quality-adjusted life-years by different preference-based instruments. Medical Care 41: pp. 791-801 CrossRef
- Marra, CA, Esdaile, JM, Guh, D, Kopec, JA, Brazier, JE, Koehler, BE, Chalmers, A, Anis, AH (2004) A comparison of four indirect methods of assessing utility values in rheumatoid arthritis. Medical Care 42: pp. 1125-1131 CrossRef
- Sach, TH, Barton, GR, Doherty, M, Muir, KR, Jenkinson, C, Avery, AJ (2007) The relationship between body mass index and health-related quality of life: Comparing the EQ-5D, EuroQol VAS and SF-6D. International Journal of Obesity (London) 31: pp. 189-196 CrossRef
- Barton, G. R., Sach, T. H., Doherty, M., Avery, A.J., Jenkinson, C., & Muir K. R. (2007). An assessment of the discriminative ability of the EQ-5D (index), SF-6D, and EQ VAS, using sociodemographic factors and clinical conditions. The European Journal of Health Economics Jun 29 [Epub ahead of print].
- Franks, P, Hanmer, J, Fryback, DG (2006) Relative disutilities of 47 risk factors and conditions assessed with seven preference-based health status measures in a national U.S. sample toward consistency in cost-effectiveness analyses. Medical Care 44: pp. 478-485 CrossRef
- Stel, HF, Buskens, E (2006) Comparison of the SF-6D and the EQ-5D in patients with coronary heart disease. Health and Quality of Life Outcomes 4: pp. 20 CrossRef
- Boonen, A, Heijde, D, Landewe, R, Tubergen, A, Mielants, H, Dougados, M, Linden, S (2007) How do the EQ-5D, SF-6D and the well-being rating scale compare in patients with ankylosing spondylitis?. Annals of the Rheumatic Diseases 66: pp. 771-777 CrossRef
- Wee, HL, Machin, D, Loke, WC, Li, SC, Cheung, YB, Luo, N, Feeny, D, Fong, KY, Thumboo, J (2007) Assessing differences in utility scores: a comparison of four widely used preference-based instruments. Value in Health 10: pp. 256-265 CrossRef
- Longworth, L, Bryan, S (2003) An empirical comparison of EQ-5D and SF-6D in liver transplant patients. Health Economics 12: pp. 1061-1067 CrossRef
- Lamers, LM, Bouwmans, CA, Straten, A, Donker, MC, Hakkaart, L (2006) Comparison of EQ-5D and SF-6D utilities in mental health patients. Health Economics 15: pp. 1229-1236 CrossRef
- Brazier, J, Roberts, J, Tsuchiya, A, Busschbach, J (2004) A comparison of the EQ-5D and SF-6D across seven patient groups. Health Economics 13: pp. 873-884 CrossRef
- Bryan, S, Longworth, L (2005) Measuring health-related utility: why the disparity between EQ-5D and SF-6D?. The European Journal of Health Economics 6: pp. 253-260 CrossRef
- Tsuchiya, A, Brazier, J, Roberts, J (2006) Comparison of valuation methods used to generate the EQ-5D and the SF-6D value sets. Journal of Health Economics 25: pp. 334-346 CrossRef
- Ferreira, PL, Ferreira, LN, Pereira, LN (2008) How consistent are utility values?. Quality of Life Research 17: pp. 1031-1042 CrossRef
- Grieve, R., Grishchenko, M., & Cairns, J. (2008). SF-6D versus EQ-5D: reasons for differences in utility scores and impact on reported cost-utility. The European Journal of Health Economics. (Epub ahead of print).
- Estimating health utilities in patients with asthma and COPD: evidence on the performance of EQ-5D and SF-6D
Quality of Life Research
Volume 18, Issue 2 , pp 267-272
- Cover Date
- Print ISSN
- Online ISSN
- Springer Netherlands
- Additional Links
- Chronic obstructive pulmonary disease (COPD)
- Health utilities
- Industry Sectors
- Author Affiliations
- 1. Covance Market Access Services Inc., Springfield House, Hyde Street, Leeds, LS2 9LH, UK
- 2. United Biosource Corporation, Bethesda, MD, USA
- 3. AstraZeneca R&D, Lund, Sweden
- 4. University of Aberdeen, Aberdeen, UK
- 5. HEORConsulting, Lund, Sweden